Jorge E Cortes

101PUBLICATIONS
282CO-AUTHORS
Predictive and prognostic markersHaematological tumoursHaematologyQuantum optics and quantum optomechanicsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (101)

|Jul 24, 2026
Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial.

|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|Jun 12, 2026
Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia.

|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.

|Apr 08, 2026
Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First.

Mark J Levis, Harry P Erba, Pau Montesinos

|Mar 24, 2026
Imatinib outcomes in chronic myeloid leukemia across diverse health care settings: a systematic review and meta-analysis.

Marisol Miranda-Galvis, Joshua Wilson, Yazmin Reategui-Almonacid

Pageof 17

Frequent Collaborators

16 joint publications

Hagop M Kantarjian

15 joint publications

Michael Mauro

12 joint publications

Andreas Hochhaus

12 joint publications

Gautam Borthakur